Protalix Biotherapeutics (PLX)
:PLX
US Market

Protalix (PLX) Income Statement

Compare
785 Followers

Protalix Income Statement

Last quarter (Q4 2024), Protalix's total revenue was $18.22M, an increase of 73.74% from the same quarter last year. In Q4, Protalix's net income was $6.49M. See Protalix’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 53.40M$ 65.49M$ 47.64M$ 38.35M$ 62.90M
Gross Profit
$ 29.08M$ 42.51M$ 28.05M$ 22.00M$ 52.02M
Operating Expenses
$ 25.16M$ 32.05M$ 41.06M$ 42.46M$ 49.31M
Depreciation and Amortization
$ 1.30M$ 1.19M$ 1.09M$ 1.12M$ 1.30M
EBITDA
$ 6.52M$ 11.65M$ -10.78M$ -18.94M$ 4.45M
Operating Income
$ 3.92M$ 10.46M$ -13.01M$ -20.46M$ 1.85M
Other Income/Expenses
$ 237.00K$ -1.89M$ -1.38M$ -7.12M$ -9.23M
Pretax Income
$ 4.15M$ 8.57M$ -14.40M$ -27.58M$ -6.52M
Net Income
$ 2.93M$ 8.31M$ -14.93M$ -33.98M$ -14.89M
Per Share Metrics
Basic EPS
$ 0.04$ 0.12$ -0.31$ -0.77$ -0.51
Diluted EPS
$ 0.04$ 0.10$ -0.31$ -0.77$ -0.51
Weighted Average Shares Outstanding
72.53M 67.51M 48.47M 44.14M 29.15M
Weighted Average Shares Outstanding (Diluted)
81.06M 82.42M 48.47M 44.14M 29.15M
Currency in USD

Protalix Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis